Loomis Sayles & CO L P Insmed Inc Transaction History

Loomis Sayles & CO L P

$77.3 Billion
Q2 2025

A detailed history of Loomis Sayles & CO L P transactions in Insmed Inc stock. As of the latest transaction made, Loomis Sayles & CO L P holds 793,569 shares of INSM stock, worth $130 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

793,569

Previous 1,009,466 21.39%

Holding current value

$130 Million

Previous $77 Million 3.7%

% of portfolio

0.1%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$64.81 - $105.9 $14 Million - $22.9 Million	-215,897 Reduced 21.39%	793,569 $79.9 Million
Q1 2025 May 14, 2025	SELL	$65.25 - $83.83 $10.8 Million - $13.9 Million	-165,325 Reduced 14.07%	1,009,466 $77 Million
Q4 2024 Feb 12, 2025	SELL	$66.29 - $76.63 $2.35 Million - $2.71 Million	-35,396 Reduced 2.92%	1,174,791 $81.1 Million
Q3 2024 Nov 13, 2024	SELL	$62.0 - $79.01 $1.03 Million - $1.31 Million	-16,539 Reduced 1.35%	1,210,187 $88.3 Million
Q2 2024 Aug 13, 2024	SELL	$22.0 - $69.71 $5.83 Million - $18.5 Million	-265,068 Reduced 17.77%	1,226,726 $82.2 Million
Q1 2024 May 14, 2024	SELL	$25.72 - $29.94 $21.6 Million - $25.1 Million	-839,711 Reduced 36.02%	1,491,794 $40.5 Million
Q4 2023 Feb 13, 2024	SELL	$23.42 - $31.74 $1.21 Million - $1.64 Million	-51,534 Reduced 2.16%	2,331,505 $72.3 Million
Q3 2023 Nov 09, 2023	BUY	$19.86 - $26.93 $15.3 Million - $20.7 Million	769,443 Added 47.68%	2,383,039 $60.2 Million
Q2 2023 Aug 11, 2023	SELL	$16.44 - $21.1 $245,317 - $314,854	-14,922 Reduced 0.92%	1,613,596 $34 Million
Q1 2023 May 11, 2023	BUY	$16.26 - $21.73 $6.53 Million - $8.72 Million	401,418 Added 32.71%	1,628,518 $27.8 Million
Q4 2022 Feb 10, 2023	SELL	$16.98 - $23.15 $498,481 - $679,614	-29,357 Reduced 2.34%	1,227,100 $24.5 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $316,645 - $427,804	-15,165 Reduced 1.19%	1,256,457 $27.1 Million
Q2 2022 Aug 05, 2022	SELL	$17.07 - $25.71 $110,459 - $166,369	-6,471 Reduced 0.51%	1,271,622 $25.1 Million
Q1 2022 May 13, 2022	SELL	$20.42 - $28.13 $498,595 - $686,850	-24,417 Reduced 1.87%	1,278,093 $30 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $1.76 Million - $2.27 Million	67,849 Added 5.5%	1,302,510 $35.5 Million
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $10.3 Million - $13.5 Million	459,411 Added 59.26%	1,234,661 $34 Million
Q2 2021 Aug 13, 2021	SELL	$24.17 - $36.01 $379,033 - $564,708	-15,682 Reduced 1.98%	775,250 $22.1 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $103,780 - $142,424	-3,215 Reduced 0.4%	790,932 $26.9 Million
Q4 2020 Feb 12, 2021	BUY	$31.45 - $40.54 $25 Million - $32.2 Million	794,147 New	794,147 $26.4 Million

Others Institutions Holding INSM

# of Institutions

582

Shares Held

203M

Call Options Held

2.84M

Put Options Held

3.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $22.1B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Insmed Inc Transaction History